• Posted: November 25, 2014 Plerixafor is superior to conventional chemotherapy for first-line stem cell...

    Clark RE, Bell J, Clark JO, Braithwaite B, Vithanarachchi U, McGinnity N, Callaghan T, Francis S, Salim R. Blood Cancer J. 2014 Oct 31;4:e255. doi:...

    READ MORE
  • Posted: November 25, 2014 Predictors of survival outcomes in phase 1 relapsed or refractory multiple...

    Barbee MS, Nooka A, Kaufman JL, Kim S, Chen Z, Heffner LT Jr, Lonial S, Harvey RD. Cancer. 2014 Nov 6. doi: 10.1002/cncr.29136. [Epub ahead of print] PMID:...

    READ MORE
  • Posted: November 25, 2014 Efficacy and safety of long-term treatment with lenalidomide and dexamethasone...

    Dimopoulos MA, Swern AS, Li JS, Hussein M, Weiss L, Nagarwala Y, Baz R. Blood Cancer J. 2014 Nov 7;4:e257. doi: 10.1038/bcj.2014.77. PMID: 25382609 [PubMed -...

    READ MORE
  • Posted: November 25, 2014 Phase 2 study of carfilzomib, thalidomide and dexamethasone as...

    Sonneveld P, Asselbergs E, Zweegman S, van der Holt B, Kersten MJ, Vellenga E, van Marwijk-Kooy M, Broyl A, de Weerdt O, Lonergan S, Palumbo A, Lokhorst...

    READ MORE
  • Posted: November 6, 2014 Statement from the Multiple Myeloma Research Foundation Regarding the Oncologic...

    The Multiple Myeloma Research Foundation (MMRF) today issued the following statement regarding the Food and Drug Administration’s (FDA) Oncologic Drugs...

    READ MORE
  • Posted: November 5, 2014 Multiple Myeloma Research Foundation Leads New Initiative to Accelerate...

    The MM Master Protocol is a biomarker-driven, clinical trial that matches patients with relapsed disease with targeted therapies based on the genomic profile...

    READ MORE
  • Posted: October 1, 2014 Multiple Myeloma Research Consortium (MMRC) Hits all Time Record-Opens Six New...

    The Multiple Myeloma Research Consortium (MMRC) today announced that it has opened six new clinical trials in 2014, and is on track to open more multiple...

    READ MORE
  • Posted: March 13, 2014 Research!America Honors Kathy Giusti, Founder and CEO of the Multiple Myeloma...

    Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation (MMRF), received Research!America's 2014 Gordon and Llura Gund Leadership Award for...

    READ MORE
  • Posted: January 13, 2014 Multiple Myeloma Research Foundation (MMRF) Research Collaboration Advances...

    The Multiple Myeloma Research Foundation (MMRF) today hailed a new publication inCancer Cell as a major step forward in the organization’s efforts to advance...

    READ MORE

Page 26/15